These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2185686)

  • 1. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X; Silva E; Gershenson D; Hung MC
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
    Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M; Volling P
    HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
    Yang Y
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.